금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Stocks Rise Pre-Bell as Traders Await Fed Policy Decision, Inflation Report, Big Tech Earnings
The benchmark US stock measures pointed higher before the opening bell Monday as traders gear up for...
Stock market today: Dow, S&P 500, Nasdaq futures rise ahead of busy week of earnings, Fed rate decision
Investors braced for a full earnings docket and the Federal Reserve's next policy decision this week...
British Pound: Stronger PMIs lean hawkish for BoE – Danske Bank
Danske Research Team notes UK flash PMIs strengthened in October, with the composite rising to 53.1 ...
Morgan Stanley Gains 45.1% in a Year: Should You Buy MS Stock Now?
MS outpaces peers with a 45.1% share price gain, but trading cyclicality, rising expenses and a premium valuation could limit further upside.
NET Power surges after securing rights to acquire 123 MW of generation capacity
Earnings Season Is Almost Done. A Big Report Is Coming Up
Investor attention will undoubtedly focus this week on the latest quarterly results from Nvidia.
Welltower, Realty Income lead S&P Real Estate stocks on growth
Focus on Mid-Week: NVIDIA Earnings, PCE Report
NVIDIA is expected to generate +99% earnings growth and PCE looks to remain high at +3.6%.
Capricor rises as FDA extends Deramiocel action date
Steel Dynamics, Nucor surge on S&P leaderboard as U.S.-Canada trade fight escalates
Estee Lauder Stock Jumped On A Bigger Margin Promise
The beauty group's repricing rests on a profit plan it controls, while the low end of its new sales guidance is no faster than the year just ended.
Domino's Stock Slips 15% in 6 Months: Should You Buy, Hold or Sell?
DPZ's 15.3% six-month slide reflects weak ticket trends and margin pressure, but order growth, loyalty gains and a discounted valuation support a hold.
Nvidia Stock: Why It May Be Raising Prices 15% and Funding AI Startups
Nvidia stock is reacting to news of the company making major AI investments and a potential price hike.
Steel Stocks Jump as U.S.-Canada Tariff Fight Escalates
Steel Dynamics, Nucor, and Cleveland-Cliffs shares rise as escalating U.S.-Canada trade tensions put steel tariffs back in focus.
SYRE Rallies 44.9% in 3 Months. Can Clinical Catalysts Sustain It?
Spyre's 2026 clinical catalysts and positive ulcerative colitis data fuel momentum, but its lofty valuation raises the stakes for upcoming readouts.